Business
Sernova Corp. Announces Voting Results of the 2023 Annual General Meeting of Shareholders
(TheNewswire) LONDON, Ontario – TheNewswire - April 2 8 , 2023 - ...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova Corp. Announces Voting Results of the 2023 Annual General Meeting of Shareholders\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n LONDON, Ontario –\n \n \n TheNewswire -\n \n \n April\n2\n \n \n 8\n \n \n , 2023 -\n \n \n Sernova Corp.\n \n \n (“\n \n \n Sernova\n \n \n ” or the\n“\n \n \n Corporation\n \n \n ”)\n \n \n (TSX:SVA) (OTC:SEOVF)\n(FSE/XETRA:PSH),\n \n \n a clinical-stage regenerative\nmedicine company and leader in cell therapeutics focused on developing\na potential ‘functional cure’ for type 1 diabetes (T1D) and other\nchronic diseases, is pleased to announce results from its Annual\nGeneral Meeting of Shareholders (the “\n \n \n AGM\n \n \n ”), held\nvirtually via live audio webcast on April 27, 2023.\n \n \n \n \n The following resolutions were proposed and approved at\nthe AGM:\n \n \n \n \n \n \n \n Dr. Philip M. Toleikis, James T. Parsons, Deborah M.\nBrown, Dr. Mohammad Azab, Dr. Daniel Mahony, Brett Whalen, Dr. Steven\nSangha and Bertram von Plettenberg were elected as directors of the\nCorporation for the ensuing year.\n \n \n \n \n \n \n Appointment of KPMG LLP, as auditors of the Company\nuntil the next annual meeting and the authorization of the directors\nof the Company to fix the remuneration to be paid to the\nauditors.\n \n \n \n \n \n \n The resolution to ratify and confirm amendments to the\nOption Plan and DSU Plan and to increase the maximum number of Common\nShares reserved for issuance was not tabled at the AGM and as such the\ncurrent incentive plan without the amendments continues in\neffect.\n \n \n \n \n “As they transition out of their director roles, I\nwould like to acknowledge Frank Holler and Jeffrey Bacha’s many\nyears of contributions to Sernova’s Board of Directors,\n \n \n ” said Dr. Philip Toleikis, President & CEO of Sernova\nCorp. “With today’s results, I would also like to welcome our two\nnew directors, Dr. Steven Sangha and Bertram von Plettenberg to the\ncompany. We look forward to working with them as we strive to advance\nthe Cell Pouch™ and work to create other therapeutic options for\npatients with chronic diseases.\n \n \n \n \n “We are honored to be given t...